IRONWOOD PHARMACEUTICALS, INC. Convertible Notes Payable
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Convertible Notes Payable of $234.24 million as of 2016-12-31, per its 10-K filed 2017-02-22.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2017-02-22
- 2016-12-31: Convertible Notes Payable $234.24M.
- 2016-09-30: Convertible Notes Payable $230.72M.
- 2016-06-30: Convertible Notes Payable $227.27M.
- 2016-03-31: Convertible Notes Payable $223.91M.
| Period end | Convertible Notes Payable |
|---|---|
| 2016-12-31 | $234.24M 10-K · filed 2017-02-22 |
| 2016-09-30 | $230.72M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $227.27M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $223.91M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $220.62M 10-K · filed 2017-02-22 |
| 2015-09-30 | $217.41M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $214.29M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |